What are the responsibilities and job description for the Director, Medical Affairs position at Eupraxia Pharma, Inc.?
Eupraxia is a clinical-stage biotechnology company focused on developing locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. DiffuSphere, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support an extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians want to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the DiffuSphere technology, versus the peaks and troughs seen with more traditional drug delivery methods. The precision of Eupraxia's DiffuSphere technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, also to be applicable in oncology, infectious disease and other critical disease areas.
Eupraxia's EP-104GI is currently in a Phase 1b / 2a trial, the RESOLVE trial, for the treatment of EoE. EP-104GI is administered as an injection into the esophageal wall, providing local delivery of drug. This is a unique treatment approach for EoE. Eupraxia also recently completed a Phase 2b clinical trial (SPRINGBOARD) of EP-104IAR for the treatment of pain due to knee osteoarthritis. The trial met its primary endpoint and three of the four secondary endpoints. In addition, Eupraxia is developing a pipeline of later and earlier-stage long-acting formulations. Potential pipeline indications include candidates for other inflammatory joint indications and oncology, each designed to improve on the activity and tolerability of currently approved drugs.
We are looking for people who would like to work for a fast-paced, growing company that fosters a creative spirit and integrated teamwork and who are eligible to work in Canada or the USA.
Job Description :
The Director Medical Affairs will be responsible for defining and implementing KOL strategies to develop and maintain positive KOL endorsement and product champions for Eupraxia in all aspects of Ep104 use, including OA, EOE and GI diseases. The role will also lead Eupraxia medical education initiatives and conference activities.
Reports to : Chief Medical Officer
Key Responsibilities :
- Develop and execute KOL strategies required to prepare the market for Eupraxia EP-104IAR (pre-approval) and EOE and proposed GI indications to position the product and the company as a leader in these arenas.
- Identify, engage and develop key opinion leaders (KOLs) in the OA / EOE / GI therapeutic areas across the US, EU and other key markets as required.
- Post approval, develop these relationships further.
- Working with operations management and the Clinical / Regulatory teams, the Director, Medical Affairs will
Define the US / EU and other market KOL strategy, including activities involving KOLs at international congresses, Advisory Boards and National / Regional meetings.
The development of Medical Affairs / Commercial budgets
Preferred Qualifications and Expertise :
Additional Attributes :
Salary Range : CAD$ 190,000 – 250,000 annually
Within the posted range, individual pay is determined by job-related skills, relevant experience, education and / or training. Please note that the range details above reflect the base pay only. A bonus will be available based upon performance and remaining in post for the agreed contract duration. We also have a competitive benefits package on offer.
This is an opportunity to work in a small, entrepreneurial, and highly motivating environment, with a strong emphasis on work / life balance and a supportive company culture.
While only short-listed candidates will be notified, we thank each applicant for their submission.
Eupraxia Pharmaceuticals 201-2067 Cadboro Bay Rd. Victoria BC, Canada, V8R 5G4
J-18808-Ljbffr
Salary : $190,000 - $250,000